Status:

UNKNOWN

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

Hoffmann-La Roche

Sanquin Research & Blood Bank Divisions

Conditions:

HIV Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate whether mycophenolate mofetil (MMF) can treat the chronic hyperactivation of the immune system and (partly) prevent the decrease of the CD4+ T-cell count in chr...

Detailed Description

\*Background: During chronic HIV-1 infection the immune system is chronically hyperactivated. This hyperactivation is considered as the main cause of CD4+ T-cell loss. Furthermore, HIV replicates most...

Eligibility Criteria

Inclusion

  • Patient is ≥ 18 years of age;
  • Patient has a proven HIV-1 infection (with antibodies against HIV-1 and a detectable plasma HIV-1 RNA measured for the first time at least 6 months prior to inclusion);
  • Patient is HIV-1 treatment naïve;
  • CD4+ T lymphocyte count \> 250 and \<= 450 \* 106/L;
  • No signs or history of AIDS defining events;
  • No use of other medications that might possibly influence the effects of MMF;
  • Male; or female sex and willingness to practice effective contraception during the study.

Exclusion

  • Plasma HIV-1 RNA \< 10.000 copies/ mL;
  • Autoimmune disease;
  • Active hepatitis B or C virus infection;
  • Other chronic diseases;
  • Recent infectious disease other than HIV-1;
  • Treatment with immunomodulatory or anti-inflammatory medication in the past 6 months;
  • For female patients: pregnancy and lactation;
  • Any other condition, illness or use of medication which according to the investigator is not compatible with the use of the study medication or which could interfere with the evaluations required by the study.

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00120419

Start Date

April 1 2005

Last Update

July 22 2009

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

OLVG

Amsterdam, North Holland, Netherlands, 1091AC

2

Academic Medical Center

Amsterdam, North Holland, Netherlands, 1105 AZ

3

Kennemer Gasthuis, location EG

Haarlem, North Holland, Netherlands, 2035RC

4

Erasmus Medical Center

Rotterdam, South Holland, Netherlands, 3015GD